新型线粒体自噬诱导剂通过减少髓系细胞活化与自身抗原呈递缓解狼疮肾炎
研究在狼疮倾向MRL/lpr和NZBWF1/J小鼠狼疮肾炎发病期给予新型线粒体自噬诱导剂UMI-77,发现其减轻肾脏炎症和损伤,并抑制树突状细胞功能及T细胞增殖。过继转移实验表明UMI-77处理狼疮供体或树突状细胞可预防MRL/MpJ小鼠的抗dsDNA IgG升高、蛋白尿和T细胞浸润。UMI-77还恢复狼疮肾炎患者髓系细胞线粒体功能。
要点
- UMI-77在两种狼疮倾向小鼠中减轻肾脏炎症和组织学损伤。
- UMI-77抑制狼疮树突状细胞促T细胞增殖功能并恢复其线粒体功能。
- UMI-77处理供体或树突状细胞可预防过继转移诱导的肾炎表现。
核心结论
- 增强线粒体自噬可限制自身免疫和肾脏炎症,靶向线粒体自噬是治疗狼疮肾炎的可行途径。
研究设计与样本
- 研究使用狼疮倾向MRL/MpJ-Faslpr和NZBWF1/J小鼠,在狼疮肾炎发病期给予UMI-77治疗。
- 采用组织学和流式细胞术评估肾脏炎症和损伤,并进行树突状细胞-T细胞共培养实验。
- 进行过继转移实验,将MRL/lpr小鼠树突状细胞转移至MRL/MpJ小鼠。
- 体外用UMI-77处理狼疮肾炎患者髓系细胞,检测ATP水平。
主要发现
- UMI-77治疗有效减轻狼疮倾向小鼠的肾脏炎症和损伤。
- UMI-77减弱树突状细胞驱动T细胞增殖的功能,但不直接影响狼疮小鼠T细胞增殖。
- UMI-77恢复狼疮树突状细胞线粒体功能并减轻促炎表型。
- 过继转移MRL/lpr树突状细胞使MRL/MpJ小鼠血清抗dsDNA IgG、尿蛋白和肾脏T细胞浸润增加,而体内处理狼疮供体或直接处理狼疮树突状细胞可预防这些变化。
- UMI-77体外恢复狼疮肾炎患者髓系细胞线粒体功能,表现为ATP水平升高。
临床怎么用
- 提示药理学增强线粒体自噬可能成为狼疮肾炎的治疗策略。
- 靶向髓系细胞线粒体自噬可能减少自身抗原呈递和T细胞介导的肾脏损伤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lupus nephritis (LN) is one of the most severe manifestations of systemic lupus erythematosus (SLE), but its mechanism of onset remains unclear. Since impaired mitophagy has been implicated in multiple organs in SLE, we hypothesized that mitophagy dysfunction is critical in the development of LN and that pharmacologically targeting mitophagy would ameliorate this disease. Therefore, lupus-prone MRL/MpJ-Faslpr (MRL/lpr) and NZBWF1/J mice were treated with a novel mitophagy inducer, UMI-77, during their onset of LN. This treatment effectively mitigated kidney inflammation and damage as assessed by histology and flow cytometry. Furthermore, dendritic cell (DC)-T-cell coculture assay indicated that UMI-77 treatment attenuated DC function that would drive T-cell proliferation but did not directly influence the potent T-cell proliferation in lupus mice. UMI-77 also restored mitochondrial function and attenuated proinflammatory phenotypes in lupus DCs. Adoptive transfer of DCs from MRL/lpr mice augmented serum anti-dsDNA IgG, urine protein and T-cell infiltration of the kidney in MRL/MpJ mice, which could be prevented by either treating lupus donors in vivo or lupus DCs directly with UMI-77. UMI-77 also restored mitochondrial function in myeloid cells from patients with LN in vitro as evidenced by increased ATP levels. Thus, enhancing mitophagy in SLE restrains autoimmunity and limits kidney inflammation for LN development. Hence, our findings suggest targeting mitophagy as a tangible pathway to treat LN.
引用
- Wang H, Shen M, Ma Y, et al. Novel mitophagy inducer alleviates lupus nephritis by reducing myeloid cell activation and autoantigen presentation. Kidney Int. 2024. PMID: 38296028. doi:10.1016/j.kint.2023.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。